Business Description
Bioteque Corp
NAICS : 334510
SIC : 3845
ISIN : TW0004107008
Description
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.9 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | 1.14 | |||||
| Interest Coverage | 52 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.64 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.1 | |||||
| 3-Year EBITDA Growth Rate | 1 | |||||
| 3-Year EPS without NRI Growth Rate | -2.5 | |||||
| 3-Year FCF Growth Rate | 9.4 | |||||
| 3-Year Book Growth Rate | 6.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.05 | |||||
| 9-Day RSI | 49.67 | |||||
| 14-Day RSI | 52 | |||||
| 6-1 Month Momentum % | 15.21 | |||||
| 12-1 Month Momentum % | 9.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.35 | |||||
| Quick Ratio | 2.05 | |||||
| Cash Ratio | 1.72 | |||||
| Days Inventory | 96.43 | |||||
| Days Sales Outstanding | 38.09 | |||||
| Days Payable | 35.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.57 | |||||
| Dividend Payout Ratio | 0.65 | |||||
| 3-Year Dividend Growth Rate | 4 | |||||
| Forward Dividend Yield % | 3.57 | |||||
| 5-Year Yield-on-Cost % | 4.52 | |||||
| Shareholder Yield % | 1.74 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.55 | |||||
| Operating Margin % | 30.08 | |||||
| Net Margin % | 24.16 | |||||
| FCF Margin % | 32.14 | |||||
| ROE % | 15.93 | |||||
| ROA % | 10.44 | |||||
| ROIC % | 17.64 | |||||
| ROC (Joel Greenblatt) % | 24.51 | |||||
| ROCE % | 16.18 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.26 | |||||
| PE Ratio without NRI | 18.26 | |||||
| Shiller PE Ratio | 18.51 | |||||
| Price-to-Owner-Earnings | 21.5 | |||||
| PEG Ratio | 5.22 | |||||
| PS Ratio | 4.41 | |||||
| PB Ratio | 2.89 | |||||
| Price-to-Tangible-Book | 2.89 | |||||
| Price-to-Free-Cash-Flow | 13.74 | |||||
| Price-to-Operating-Cash-Flow | 12.43 | |||||
| EV-to-EBIT | 12.88 | |||||
| EV-to-EBITDA | 10.27 | |||||
| EV-to-Revenue | 4 | |||||
| EV-to-FCF | 12.44 | |||||
| Price-to-Projected-FCF | 1.64 | |||||
| Price-to-DCF (Earnings Based) | 1.19 | |||||
| Price-to-DCF (FCF Based) | 0.89 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Graham-Number | 1.53 | |||||
| Price-to-Net-Current-Asset-Value | 15.65 | |||||
| Earnings Yield (Greenblatt) % | 7.76 | |||||
| FCF Yield % | 7.31 | |||||
| Forward Rate of Return (Yacktman) % | 5.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioteque Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,985.026 | ||
| EPS (TTM) (NT$) | 6.9 | ||
| Beta | 0.29 | ||
| Volatility % | 11.56 | ||
| 14-Day RSI | 52 | ||
| 14-Day ATR (NT$) | 2.749311 | ||
| 20-Day SMA (NT$) | 125.075 | ||
| 12-1 Month Momentum % | 9.65 | ||
| 52-Week Range (NT$) | 102 - 134.5 | ||
| Shares Outstanding (Mil) | 69.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioteque Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioteque Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioteque Corp Frequently Asked Questions
What is Bioteque Corp(ROCO:4107)'s stock price today?
The current price of ROCO:4107 is NT$126.00. The 52 week high of ROCO:4107 is NT$134.50 and 52 week low is NT$102.00.
When is next earnings date of Bioteque Corp(ROCO:4107)?
The next earnings date of Bioteque Corp(ROCO:4107) is .
Does Bioteque Corp(ROCO:4107) pay dividends? If so, how much?
The Dividend Yield %  of Bioteque Corp(ROCO:4107) is 3.57% (As of Today), Highest Dividend Payout Ratio of Bioteque Corp(ROCO:4107) was 0.69. The lowest was 0.46. And the median was 0.6. The  Forward Dividend Yield % of Bioteque Corp(ROCO:4107) is 3.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers